Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study
Journal
Transplantation
Journal Volume
103
Journal Issue
9
Pages
1953
Date Issued
2019-09
Author(s)
Tedesco-Silva, Helio
Pascual, Julio
Viklicky, Ondrej
Basic-Jukic, Nikolina
Cassuto, Elisabeth
Kim, Dean Y
Cruzado, Josep M
Sommerer, Claudia
Adel Bakr, Mohamed
Garcia, Valter D
et al.,
Abstract
The safety profiles of standard therapy versus everolimus with reduced-exposure calcineurin inhibitor (CNI) therapy using contemporary protocols in de novo kidney transplant recipients have not been compared in detail.
Subjects
WOUND-HEALING COMPLICATIONS; RENAL-TRANSPLANTATION; MYCOPHENOLIC-ACID; CYTOMEGALOVIRUS-INFECTION; MTOR INHIBITORS; RISK-FACTORS; RECIPIENTS; SIROLIMUS; TACROLIMUS; EFFICACY
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Type
journal article